1. Home
  2. WKSP vs INTS Comparison

WKSP vs INTS Comparison

Compare WKSP & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$1.37

Market Cap

20.4M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.22

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKSP
INTS
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WKSP
INTS
Price
$1.37
$0.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$9.25
$2.25
AVG Volume (30 Days)
230.0K
1.4M
Earning Date
03-26-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,286,679.00
N/A
Revenue This Year
$135.39
N/A
Revenue Next Year
$116.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
123.37
N/A
52 Week Low
$1.40
$0.19
52 Week High
$9.10
$2.50

Technical Indicators

Market Signals
Indicator
WKSP
INTS
Relative Strength Index (RSI) 26.85 23.38
Support Level $1.40 $0.34
Resistance Level $1.75 $0.39
Average True Range (ATR) 0.17 0.02
MACD -0.02 -0.01
Stochastic Oscillator 12.84 3.99

Price Performance

Historical Comparison
WKSP
INTS

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: